What's happening
This bill decriminalizes the possession of buprenorphine in New York State.
Why it matters
Reduces legal barriers for people using buprenorphine. , a medication proven to help treat opioid use disorder, making it easier to access without fear of arrest or prosecution.
Encourages harm reduction and public health approaches. by shifting away from criminal penalties for possession, potentially leading to lower overdose rates and increased willingness among people to seek help.
Removes buprenorphine from the definition of “controlled substance” and “narcotic preparation”. under New York’s penal law, meaning police and courts will no longer treat its possession as a drug crime.
Signals a broader shift in drug policy. , prioritizing treatment and recovery over punishment, which could influence future reforms for other medications or substances used in addiction care.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
People possessing buprenorphine
The bill would exclude buprenorphine from the Penal Law definitions of “controlled substance” and “narcotic preparation,” removing it from possession offenses that rely on those definitions.
Police and prosecutors
The bill would narrow the substances covered by drug offenses that use these definitions, excluding buprenorphine.
Criminal defense attorneys
The exclusions would change the statutory basis for defending clients charged with drug offenses involving buprenorphine.
Headline styles
Allow Buprenorphine Possession
Plain English, a few words. Used as the page title.
Sponsors
20 Co-sponsors
History
- Referred to codes
- Print number 4013a
- Amend and recommit to codes
- Referred to codes
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Decriminalize Buprenorphine Possession
In Senate Committee · Codes · Sponsor Gustavo Rivera
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4013--A
2023-2024 Regular Sessions
IN ASSEMBLY
February 8, 2023
Introduced by M. of A. L. ROSENTHAL, DINOWITZ, STECK, SIMON, REYES, GONZALEZ-ROJAS, MAMDANI, BURDICK, FORREST, HEVESI, CRUZ, CLARK, GALLAGHER, TAYLOR, WEPRIN, WALKER -- read once and referred to the Committee on Codes -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the penal law, in relation to decriminalizing the possession of buprenorphine
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivisions 5 and 8 of section 220.00 of the penal law, subdivision 5 as amended by chapter 92 of the laws of 2021 and subdivision 8 as amended by section 18 of part C of chapter 447 of the laws of 2012, are amended to read as follows:
5. "Controlled substance" means any substance listed in schedule I, II, III, IV or V of section thirty-three hundred six of the public health law other than buprenorphine.
8. "Narcotic preparation" means any controlled substance listed in schedule II(b-1), III(d) or III(e), other than buprenorphine.
§ 2. This act shall take effect on the first of November next succeeding the date on which it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD06669-02-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.